Maria-Ancuta Jurj
Maria-Ancuta Jurj
Iuliu Hatieganu University of Medicine and Pharmacy Cluj Napoca
No verified email
Cited by
Cited by
The new era of nanotechnology, an alternative to change cancer treatment
A Jurj, C Braicu, LA Pop, C Tomuleasa, CD Gherman, I Berindan-Neagoe
Drug design, development and therapy 11, 2871, 2017
Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer
F Zaharie, MS Muresan, B Petrushev, C Berce, GA Gafencu, S Selicean, ...
J Gastrointestin Liver Dis 24 (4), 435-443, 2015
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression
D Gulei, L Magdo, A Jurj, L Raduly, R Cojocneanu-Petric, A Moldovan, ...
Cell Death & Disease 9 (2), 1-16, 2018
How to Diagnose and Treat a Cancer of Unknown Primary Site.
C Tomuleasa, F Zaharie, MS Muresan, L Pop, Z Fekete, D Dima, I Frinc, ...
Journal of Gastrointestinal & Liver Diseases 26 (1), 2017
Future trends and emerging issues for nanodelivery systems in oral and oropharyngeal cancer
AI Irimie, L Sonea, A Jurj, N Mehterov, AA Zimta, L Budisan, C Braicu, ...
International Journal of Nanomedicine 12, 4593, 2017
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapy
B Petrushev, S Boca, T Simon, C Berce, I Frinc, D Dima, S Selicean, ...
International journal of nanomedicine 11, 641, 2016
Antibody conjugated, raman tagged hollow gold–silver nanospheres for specific targeting and multimodal dark-field/sers/two photon-flim imaging of CD19 (+) B Lymphoblasts
T Nagy-Simon, AS Tatar, AM Craciun, A Vulpoi, MA Jurj, A Florea, ...
ACS Applied Materials & Interfaces 9 (25), 21155-21168, 2017
Aberrant miRNAs expressed in HER-2 negative breast cancers patient
C Braicu, L Raduly, G Morar-Bolba, R Cojocneanu, A Jurj, LA Pop, ...
Journal of Experimental & Clinical Cancer Research 37 (1), 257, 2018
miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples
OL Braicu, L Budisan, R Buiga, A Jurj, P Achimas-Cadariu, LA Pop, ...
OncoTargets and therapy 10, 4225, 2017
Implications of dietary ω‑3 and ω‑6 polyunsaturated fatty acids in breast cancer
O Zanoaga, A Jurj, L Raduly, R Cojocneanu‑Petric, E Fuentes‑Mattei, ...
Experimental and therapeutic medicine 15 (2), 1167-1176, 2018
Antiproliferative and apoptotic effects of lidocaine on human hepatocarcinoma cells. A preliminary study
A Jurj, C Tomuleasa, TT Tat, I Berindan-Neagoe, SV Vesa, DC Ionescu
J Gastrointestin Liver Dis 26 (1), 45-50, 2017
miR‐181a/b therapy in lung cancer: reality or myth?
C Braicu, D Gulei, R Cojocneanu, L Raduly, A Jurj, E Knutsen, GA Calin, ...
Molecular oncology 13 (1), 9-25, 2019
Chimeric antigen receptor T-cells for the treatment of B-cell acute lymphoblastic leukemia
C Tomuleasa, S Fuji, C Berce, A Onaciu, S Chira, B Petrushev, WT Micu, ...
Frontiers in immunology 9, 239, 2018
Inhibitory effect of CAPE and kaempferol in colon cancer cell lines—possible implications in new therapeutic strategies
L Budisan, D Gulei, A Jurj, C Braicu, O Zanoaga, R Cojocneanu, L Pop, ...
International journal of molecular sciences 20 (5), 1199, 2019
Microarray based gene expression analysis of Sus Scrofa duodenum exposed to zearalenone: significance to human health
C Braicu, R Cojocneanu-Petric, A Jurj, D Gulei, I Taranu, AM Gras, ...
BMC genomics 17 (1), 1-10, 2016
Evaluation of cellular and molecular impact of zearalenone and Escherichia coli co-exposure on IPEC-1 cells using microarray technology
C Braicu, S Selicean, R Cojocneanu-Petric, R Lajos, O Balacescu, ...
BMC genomics 17 (1), 576, 2016
Premature senescence activation in DLD‑1 colorectal cancer cells through adjuvant therapy to induce a miRNA profile modulating cellular death
S Chira, L Raduly, C Braicu, A Jurj, R Cojocneanu‑Petric, L Pop, ...
Experimental and therapeutic medicine 16 (2), 1241-1249, 2018
Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome
A Jurj, L Pop, B Petrushev, S Pasca, D Dima, I Frinc, D Deak, ...
Critical Reviews in Clinical Laboratory Sciences 55 (7), 501-515, 2018
Protein dysregulation in graft versus host disease
L Qian, D Dima, C Berce, Y Liu, I Rus, LZ Raduly, Y Liu, B Petrushev, ...
Oncotarget 9 (1), 1483, 2018
Ruxolitinib-conjugated gold nanoparticles for topical administration: An alternative for treating alopecia?
S Boca, C Berce, A Jurj, B Petrushev, L Pop, GA Gafencu, S Selicean, ...
Medical Hypotheses 109, 42-45, 2017
The system can't perform the operation now. Try again later.
Articles 1–20